We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+14.29%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$2.45B
AUM Growth
+$519M
Cap. Flow
-$25.5M
Cap. Flow %
-1.04%
Top 10 Hldgs %
32.76%
Holding
158
New
53
Increased
22
Reduced
25
Closed
33

Top Buys

Rank Stock Value
1
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$90.2M
2
LH icon
Labcorp
LH
+$65.9M
3
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
+$53.4M
4
ABBV icon
AbbVie
ABBV
+$51.8M
5
ITMN
INTERMUNE INC
ITMN
+$35.3M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$43.2M
2
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$41.1M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$37.6M
4
GMED icon
Globus Medical
GMED
+$34.2M
5
QCOR
QUESTCOR PHARMA INC
QCOR
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 43.78%
2 Technology 1.21%
3 Financials 0.56%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALIM
51
DELISTED
Alimera Sciences
ALIM
$10.3M 0.42%
+87,419
New +$8.49M
SPPI
52
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$9.92M 0.41%
1,265,375
-1,096,030
-46% -$9.28M
BCRX icon
53
BioCryst Pharmaceuticals
BCRX
$2.37B
$9.61M 0.39%
907,920
+39,350
+5% +$420K
ZLTQ
54
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$9.48M 0.39%
+483,520
New +$9.43M
IART icon
55
Integra LifeSciences
IART
$1.54B
$9.48M 0.39%
504,286
-161,289
-24% -$3.11M
BLUE
56
DELISTED
bluebird bio
BLUE
$9.43M 0.38%
31,997
-676
-2% -$205K
ELGX
57
DELISTED
Endologix Inc
ELGX
$8.8M 0.36%
+68,346
New +$10.6M
CNCE
58
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$8.31M 0.34%
+617,649
New +$8.72M
PTCT icon
59
PTC Therapeutics
PTCT
$6.37B
$8.3M 0.34%
317,530
-227,497
-42% -$6.11M
VNDA icon
60
Vanda Pharmaceuticals
VNDA
$312M
$8.15M 0.33%
501,709
-129,567
-21% -$1.84M
NSTG
61
DELISTED
NanoString Technologies, Inc.
NSTG
$8.08M 0.33%
391,105
-233,606
-37% -$4.45M
SNDA icon
62
Sonida Senior Living
SNDA
$1.97B
$8.01M 0.33%
20,539
-74,002
-78% -$26.9M
WINT
63
DELISTED
Windtree Therapeutics Inc
WINT
$7.87M 0.32%
261,407
– –
CNC icon
64
Centene
CNC
$31.3B
$7.77M 0.32%
499,180
-752,068
-60% -$11.6M
ARNA
65
DELISTED
Arena Pharmaceuticals Inc
ARNA
$7.66M 0.31%
121,658
– –
KBIO
66
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
$7.55M 0.31%
+348,348
New +$10.1M
CASM
67
DELISTED
CAS Medical Systems, Inc.
CASM
$6.94M 0.28%
3,200,000
– –
AUXL
68
PUT
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$6.79M 0.28%
+250,000
New +$6.64M
AMED
69
DELISTED
Amedisys
AMED
$6.54M 0.27%
+439,000
New +$6.76M
BAX icon
70
Baxter International
BAX
$11.6B
$6.25M 0.26%
156,485
-32,218
-17% -$1.2M
ATEC icon
71
Alphatec Holdings
ATEC
$1.27B
$5.97M 0.24%
331,895
– –
INGN icon
72
Inogen
INGN
$167M
$5.9M 0.24%
+357,269
New +$6.35M
STRM
73
DELISTED
Streamline Health Solutions
STRM
$5.74M 0.23%
76,007
+54,340
+251% +$5.05M
ANTH
74
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$5.67M 0.23%
211,482
– –
VRTX icon
75
Vertex Pharmaceuticals
VRTX
$121B
$5.55M 0.23%
+78,500
New +$6.22M
1 2
3
4 5

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q1 2014 Portfolio in Review

As of Q1 2014, Deerfield Management held 158 positions worth $2.45B, up 27% from $1.93B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Deerfield Management's Q1 2014 filing shows 53 new, 22 increased, 25 reduced and 33 closed positions. Its largest new stake was Dicerna Pharmaceuticals, Inc.: 2,428,569 shares worth $68.6M. The largest sale was Humana, an estimated $43.2M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 46% a quarter earlier, followed by Technology and Financials.

  • Deerfield Management's largest Q1 2014 buy was Dicerna Pharmaceuticals, Inc.: 2,428,569 shares worth $68.6M.
  • Deerfield Management added most to Insmed in Q1 2014, an estimated $18.3M increase.
  • Deerfield Management's biggest Q1 2014 reduction was AUXILIUM PHARAMCEUTICALS INC, cutting an estimated $41.1M.
  • Deerfield Management fully exited Humana in Q1 2014, selling an estimated $43.2M.
  • Deerfield Management's ten largest holdings make up 33% of its $2.45B portfolio in Q1 2014.
  • Deerfield Management opened 53 new positions and closed 33 in Q1 2014.
  • Deerfield Management's portfolio value rose 27% quarter-over-quarter to $2.45B.

Based on Deerfield Management's 13F filing for Q1 2014, filed 15 May 2014.